CIBA 24 (Cytadren 250 mg)
Generic Name: aminoglutethimide
Pill imprint CIBA 24 has been identified as Cytadren 250 mg.
Cytadren is used in the treatment of cushing's syndrome; prostate cancer; breast cancer and belongs to the drug class adrenal corticosteroid inhibitors. There is positive evidence of human fetal risk during pregnancy. Cytadren 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- aminoglutethimide
- Imprint:
- CIBA 24
- Strength:
- 250 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Adrenal corticosteroid inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00083-0024
More about Cytadren (aminoglutethimide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
